🟢 Oncolytics Biotech is trading 6.75% up today — no clear company-specific catalyst identified

Oncolytics Biotech is trading 6.75% up at $0.80, with no clear company-specific catalyst identified for the September 14 move.

• The move reverses its recent decline from a $0.75 close on September 11, 2026.
• A September 10 announcement described positive preclinical pelareorep results with a pan-RAS inhibitor in colorectal cancer, but available reporting does not directly link it to today’s trading.
• Broader markets are lower, so the move is not explained by overall market direction. Confidence remains low pending further disclosures.